We are live on ! Find out more
Jacobs Levy Equity Management

Jacobs Levy Equity Management Portfolio holdings

AUM $23.8B
1-Year Est. Return 25.4%
This Fund
S&P 500
This Quarter Est. Return
+6.26%
1 Year Est. Return
+25.4%
3 Year Est. Return
+87.35%
5 Year Est. Return
+125.75%
10 Year Est. Return
+515.94%
AUM
$5.69B
AUM Growth
+$546M
Cap. Flow
+$263M
Cap. Flow %
4.63%
Top 10 Hldgs %
11.85%
Holding
1,134
New
196
Increased
491
Reduced
251
Closed
159

Top Buys

Rank Stock Value
1
BMY icon
Bristol-Myers Squibb
BMY
+$35.7M
2
MRK icon
Merck
MRK
+$30.3M
3
MSFT icon
Microsoft
MSFT
+$22.4M
4
YUMC icon
Yum China
YUMC
+$17.6M
5
OXY icon
Occidental Petroleum
OXY
+$17.3M

Sector Composition

Rank Sector Weight
1 Technology 19.48%
2 Financials 17.92%
3 Industrials 13.48%
4 Consumer Discretionary 11.28%
5 Healthcare 10.48%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
EPZM
726
DELISTED
Epizyme, Inc
EPZM
$565K 0.01%
44,990
+31,600
+236% +$459K
CCL icon
727
Carnival Corporation Ltd
CCL
$36.1B
$552K 0.01%
+8,320
New +$551K
IVAC
728
DELISTED
Intevac Inc
IVAC
$551K 0.01%
80,399
+66,099
+462% +$507K
NPTN
729
DELISTED
NEOPHOTONICS CORP
NPTN
$550K 0.01%
83,600
+69,300
+485% +$423K
RRTS
730
DELISTED
RoadRunner Transportation Systems, Inc.
RRTS
$550K 0.01%
+2,854
New +$608K
YELL
731
DELISTED
Yellow Corporation Common Stock
YELL
$550K 0.01%
+38,240
New +$504K
ARDX icon
732
Ardelyx
ARDX
$1.24B
$549K 0.01%
83,214
+43,800
+111% +$260K
TNAV
733
DELISTED
Telenav Inc.
TNAV
$546K 0.01%
99,324
+7,867
+9% +$43.9K
TIF
734
DELISTED
Tiffany & Co.
TIF
$546K 0.01%
+5,250
New +$500K
CLDX icon
735
Celldex Therapeutics
CLDX
$2.77B
$544K 0.01%
12,773
+5,026
+65% +$215K
MRT
736
DELISTED
MedEquities Realty Trust, Inc.
MRT
$543K 0.01%
48,426
+24,285
+101% +$275K
AKBA icon
737
Akebia Therapeutics
AKBA
$327M
$541K 0.01%
36,410
+14,620
+67% +$242K
LION
738
DELISTED
Fidelity Southern Corporation
LION
$539K 0.01%
+24,710
New +$546K
SPTN
739
DELISTED
SpartanNash
SPTN
$527K 0.01%
+19,746
New +$491K
CFMS
740
DELISTED
Conformis, Inc. Common Stock
CFMS
$527K 0.01%
+8,851
New +$707K
CSLT
741
DELISTED
CASTLIGHT HEALTH, INC.
CSLT
$526K 0.01%
140,142
+99,740
+247% +$399K
RHP icon
742
Ryman Hospitality Properties
RHP
$8.4B
$525K 0.01%
+7,610
New +$509K
ADNT icon
743
Adient
ADNT
$1.6B
$520K 0.01%
+6,610
New +$533K
MRTX
744
DELISTED
Mirati Therapeutics, Inc. Common Stock
MRTX
$520K 0.01%
28,500
+5,000
+21% +$77.6K
HTB
745
HomeTrust Bancshares
HTB
$818M
$516K 0.01%
20,024
+10,544
+111% +$277K
KPTI icon
746
Karyopharm Therapeutics
KPTI
$168M
$511K 0.01%
3,547
+1,907
+116% +$306K
CWBC
747
Community West Bancshares
CWBC
$678M
$509K 0.01%
+25,202
New +$516K
USAK
748
DELISTED
USA Truck Inc
USAK
$509K 0.01%
+28,100
New +$455K
PEGA icon
749
Pegasystems
PEGA
$4.41B
$508K 0.01%
+21,540
New +$578K
FRME icon
750
First Merchants
FRME
$2.72B
$504K 0.01%
11,972
-14,100
-54% -$602K

Similar funds

Jacobs Levy Equity Management's Q4 2017 Portfolio in Review

As of Q4 2017, Jacobs Levy Equity Management held 1,134 positions worth $5.69B, up 11% from $5.14B the previous quarter. Its ten largest holdings account for 12% of the portfolio.

Jacobs Levy Equity Management deployed $263M of net new capital in Q4 2017, opening 196 new positions and adding to 491 existing holdings. Its largest new stake was Yum China: 427,927 shares worth $17.1M.

By sector, the portfolio is most concentrated in Technology at 19% of assets, down from 20% a quarter earlier, followed by Financials and Industrials.

On the sell side, the largest reduction was Johnson & Johnson, an estimated $36.5M trimmed.

  • Jacobs Levy Equity Management's largest Q4 2017 buy was Yum China: 427,927 shares worth $17.1M.
  • Jacobs Levy Equity Management added most to Bristol-Myers Squibb in Q4 2017, an estimated $35.7M increase.
  • Jacobs Levy Equity Management's biggest Q4 2017 reduction was Johnson & Johnson, cutting an estimated $36.5M.
  • Jacobs Levy Equity Management fully exited Twenty-First Century Fox, Inc. Class A in Q4 2017, selling an estimated $17.1M.
  • Jacobs Levy Equity Management's ten largest holdings make up 12% of its $5.69B portfolio in Q4 2017.
  • Jacobs Levy Equity Management opened 196 new positions and closed 159 in Q4 2017.
  • Jacobs Levy Equity Management's portfolio value rose 11% quarter-over-quarter to $5.69B.

Based on Jacobs Levy Equity Management's 13F filing for Q4 2017, filed 13 Feb 2018.